Terns Pharmaceuticals, Inc. (TERN) Costs and Expenses USD 2020 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
Terns Pharmaceuticals, Inc. quarterly/annual Costs and Expenses history and growth rate from 2020 to 2024.
  • Terns Pharmaceuticals, Inc. Costs and Expenses for the quarter ending March 31, 2024 was $25.4 M, a 5.34% increase year-over-year.
  • Terns Pharmaceuticals, Inc. Costs and Expenses for the twelve months ending March 31, 2024 was $104 M, a 43.5% increase year-over-year.
  • Terns Pharmaceuticals, Inc. annual Costs and Expenses for 2023 was $103 M, a 65.3% increase from 2022.
  • Terns Pharmaceuticals, Inc. annual Costs and Expenses for 2022 was $62 M, a 22% increase from 2021.
  • Terns Pharmaceuticals, Inc. annual Costs and Expenses for 2021 was $50.9 M, a 37.4% increase from 2020.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Quarterly (USD)
Costs and Expenses, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $104 M $25.4 M +$1.29 M +5.34% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-13
Q4 2023 $103 M $24.1 M +$7.23 M +43% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-14
Q3 2023 $95.3 M $33.2 M +$15.9 M +91.9% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $79.4 M $21.2 M +$7.08 M +50.2% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $72.4 M $24.2 M +$10.3 M +74.7% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-13
Q4 2022 $62 M $16.8 M +$1.95 M +13.1% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-14
Q3 2022 $60.1 M $17.3 M +$5.42 M +45.7% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 $54.7 M $14.1 M +$3.27 M +30.2% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 $51.4 M $13.8 M +$529 K +3.98% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 $50.9 M $14.9 M +$6.11 M +69.7% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-27
Q3 2021 $44.8 M $11.9 M +$3.13 M +35.8% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 $41.6 M $10.8 M +$721 K +7.14% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 $40.9 M $13.3 M +$3.87 M +41.1% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 $37 M $8.77 M Oct 1, 2020 Dec 31, 2020 10-K 2022-03-07
Q3 2020 $8.74 M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 $10.1 M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q1 2020 $9.42 M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.